tiprankstipranks
Petros Pharmaceuticals announces two upcoming FDA meetings on STENDRA
PremiumThe FlyPetros Pharmaceuticals announces two upcoming FDA meetings on STENDRA
3M ago
Petros completes initial cohort of Phase 2 equivalent SSS for STENDRA
PremiumThe Fly
Petros completes initial cohort of Phase 2 equivalent SSS for STENDRA
3M ago
Petros Pharmaceuticals completes Human Factors Study for STENDRA
PremiumThe Fly
Petros Pharmaceuticals completes Human Factors Study for STENDRA
5M ago
Petros Pharmaceuticals announces outcomes in label comprehension study
PremiumThe FlyPetros Pharmaceuticals announces outcomes in label comprehension study
7M ago
Petros Pharmaceuticals files to sell 422K shares of common stock for holders
PremiumThe Fly
Petros Pharmaceuticals files to sell 422K shares of common stock for holders
9M ago
Petros Pharmaceuticals Responds to Fraudulent Press Release
PremiumPress Releases
Petros Pharmaceuticals Responds to Fraudulent Press Release
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100